hearX® becomes the first to receive funding from the assistive technology impact fund..

January 26, 2021

Search for articles by category

On the International Day of People with Disabilities, 03 December 2020, the new Assistive Technology Impact Fund (ATIF) was launched out of the UK Aid-funded AT2030 programme, led by the Global Disability Innovation Hub (GDI Hub). The ATIF was established to offer support to innovators and entrepreneurs to get Assistive Technology solutions for low- and middle-income populations on a path to scale and are committed to improving the lives of people living with disabilities.

hearX Group was delighted to be announced as the ATIF’s first investment and received £200,000 in grant capital alongside 6 months of venture-building support. This investment enables hearX® to provide hearing aids through a subscription model on continental Africa and also provides an opportunity to test various distribution models in Kenya, to ensure that the product can be accessed by everyone, wherever they are located.

{% img blog-2021-26-Quote_1.svg %}

hearX’s innovative, direct-to-consumer product makes it possible for lay-health workers to detect hearing needs and demonstrate how hearing aids can help, all in one sitting. This subscription model makes high-quality hearing aids affordable and accessible. With the support of the ATIF, hearX will be able to widely scale up across Kenya and other African countries where 97% of people requiring hearing aids can’t access them.

{% img blog-2021-26-Quote_2.svg %}

{% img blog-2021-26-Quote_3.svg %}


For more information on hearX Group, please visit: hearxgroup.com

Disclaimer: The opinions expressed in the publications are those of the authors. They do not reflect the opinions or beliefs of hearX Group or its subsidiaries. The information contained herein is solely for informational purposes. It is not intended to be a substitute for professional medical advice and should not be relied upon as healthcare or medical advice. You are advised to seek guidance from your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking medical advice or care because of the content published herein. If you choose to rely on any information provided by hearX Group or its subsidiaries, you do so entirely at your own risk.

Newsletter

hearX is committed to protecting your privacy and ensuring that personal information is collected and used lawfully and transparently. We use the information provided to contact you about relevant products, services and content. You may unsubscribe at any time. Privacy Policy

Press and mediaPublished researchCareersShipping and returnsPAIA manual
BlogImpact reportsContact usTerms and conditionsPricing
hearX Group info@hearxgroup.com US: +1 (415) 825-3064 RSA: +27 (0) 12 030-0268
Lexie Hearing sales@lexiehearing.com +1 (800) 499-1336
hearX is SOC2® compliant.

This globally recognized attestation validates our commitment to critical security standards to protect and secure client data

FDA Registered | ISO 13485 Certified | SAHPRA Registered | HIPAA Compliant | POPIA Compliant

To report unethical behavior, misconduct or harassment click here.

For any feedback or complaints, please contact: support@hearxgroup.com.

© 2016-2024 hearX IP (Pty) Ltd. Copyright in this work including its layout and the design contained herein is reserved and the making of copies is prohibited.